Autopsy report · NCT00064987
Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism
Cause of deathOther
“Recruitment was at a standstill. We are currently preparing our results for publication.”
Life of this trial
- Registered 2 years 3 months after it had already started.
- Ran for about 11 years 6 months before it stopped.
- 19 participants enrolled.
- Results were posted on the registry 4 years 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Sponsor type
- US National Institutes of Health
- Conditions
- Hypogonadism; Kallmann Syndrome
- Interventions
- Testicular biopsy; gonadotropin releasing hormone (GnRH); follicle stimulating hormone (FSH)
- Participants
- 19
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)
“Study did not start. Another protocol is being developed. Recruitment on hold.” - Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
“Issues with recruitment.” - A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery
“Recruitment issues” - Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study)
“Recruitment difficulities” - GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
“Anticipated recruitment challenges”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.